This study was designed to determine whether the plasma level of apolipoprotein A-I is a better discriminator of angiographically documented coronary-artery disease than the level of high-density-lipoprotein (HDL) cholesterol in male subjects. The level of plasma apolipoprotein A-I in 83 patients with coronary-artery disease was 96.7 +/- 4.2 mg per deciliter (mean +/- S.E.M.), which was significantly lower (P less than 0.0001) than the level in 25 patients without coronary-artery disease (146.9 +/- 2.1 mg per deciliter). The levels of HDL cholesterol were also lower (P less than 0.0001) in patients with coronary-artery disease (31.9 +/- 1.5 mg per deciliter) than in those without it (45.9 +/- 2.3 mg per deciliter). A stepwise discriminant analysis, however, indicated the superiority of apolipoprotein A-I over HDL cholesterol in detecting coronary-artery disease. Furthermore, a linear discriminant analysis suggested that although HDL cholesterol by itself was a discriminator of coronary-artery disease, it did not provide a substantial increase in discriminatory value over that provided by apolipoprotein A-I; in contrast, apolipoprotein A-I levels added discriminatory value to the information obtained by measuring HDL cholesterol alone. We conclude that apolipoprotein A-I by itself is more useful than HDL cholesterol for identifying patients with coronary-artery disease.
This article has been cited by other articles:
Deguchi, H., Pecheniuk, N. M., Elias, D. J., Averell, P. M., Griffin, J. H.
(2005). High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men. Circulation
112: 893-899
[Abstract][Full Text]
Futterman, L. G., Lemberg, L.
(2005). Apo A-I Milano. Am J Crit Care
14: 244-247
[Full Text]
Meisinger, C., Loewel, H., Mraz, W., Koenig, W.
(2005). Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J
26: 271-278
[Abstract][Full Text]
Drexel, H., Aczel, S., Marte, T., Benzer, W., Langer, P., Moll, W., Saely, C. H.
(2005). Is Atherosclerosis in Diabetes and Impaired Fasting Glucose Driven by Elevated LDL Cholesterol or by Decreased HDL Cholesterol?. Diabetes Care
28: 101-107
[Abstract][Full Text]
Lin, S.-K., Kao, J.-T., Tsai, S.-M., Tsai, L.-Y., Lin, M.-N., Lai, C.-J., Zhong, W.-L.
(2004). Association of Apolipoprotein E Genotypes with Serum Lipid Profiles in a Healthy Population of Taiwan. Annals of Clinical & Laboratory Science
34: 443-448
[Abstract][Full Text]
Moore, R. E., Kawashiri, M.-a., Kitajima, K., Secreto, A., Millar, J. S., Pratico, D., Rader, D. J.
(2003). Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor. Arterioscler. Thromb. Vasc. Bio.
23: 1914-1920
[Abstract][Full Text]
Belalcazar, L. M., Merched, A., Carr, B., Oka, K., Chen, K.-H., Pastore, L., Beaudet, A., Chan, L.
(2003). Long-Term Stable Expression of Human Apolipoprotein A-I Mediated by Helper-Dependent Adenovirus Gene Transfer Inhibits Atherosclerosis Progression and Remodels Atherosclerotic Plaques in a Mouse Model of Familial Hypercholesterolemia. Circulation
107: 2726-2732
[Abstract][Full Text]
Sako, T., Uchida, E., Kagawa, Y., Hirayama, K., Nakade, T., Taniyama, H.
(2003). Immunohistochemical Detection of Apolipoprotein A-I and B-100 in Canine Atherosclerotic Lesions. Vet Pathol
40: 328-331
[Abstract][Full Text]
Kishida, T., Nogami, H., Ogawa, H., Ebihara, K.
(2002). The Hypocholesterolemic Effect of High Amylose Cornstarch in Rats Is Mediated by an Enlarged Bile Acid Pool and Increased Fecal Bile Acid Excretion, Not by Cecal Fermented Products. J. Nutr.
132: 2519-2524
[Abstract][Full Text]
Levinson, S. S.
(2002). High Density- and Beta-Lipoprotein Screening for Risk of Coronary Artery Disease in the Context of New Findings on Reverse Cholesterol Transport. Annals of Clinical & Laboratory Science
32: 123-136
[Abstract][Full Text]
Walden, C. E., Retzlaff, B. M., Buck, B. L., Wallick, S., McCann, B. S., Knopp, R. H.
(2000). Differential Effect of National Cholesterol Education Program (NCEP) Step II Diet on HDL Cholesterol, Its Subfractions, and Apoprotein A-I Levels in Hypercholesterolemic Women and Men After 1 Year : The beFIT Study. Arterioscler. Thromb. Vasc. Bio.
20: 1580-1587
[Abstract][Full Text]
Yu, H. H., Ginsburg, G. S., O'Toole, M. L., Otvos, J. D., Douglas, P. S., Rifai, N.
(1999). Acute Changes in Serum Lipids and Lipoprotein Subclasses in Triathletes as Assessed by Proton Nuclear Magnetic Resonance Spectroscopy. Arterioscler. Thromb. Vasc. Bio.
19: 1945-1949
[Abstract][Full Text]
Dallinger, G., Oberkofler, H., Seelos, C., Patsch, W.
(1999). Transcriptional elongation of the rat apolipoprotein A-I gene: identification and mapping of two arrest sites and their signals. J. Lipid Res.
40: 1229-1239
[Abstract][Full Text]
Chan, P. T., Fong, W. P., Cheung, Y. L., Huang, Y., Ho, W. K. K., Chen, Z.-Y.
(1999). Jasmine Green Tea Epicatechins Are Hypolipidemic in Hamsters (Mesocricetus auratus) Fed a High Fat Diet. J. Nutr.
129: 1094-1101
[Abstract][Full Text]
Rainwater, D. L., McMahan, C. A., Malcom, G. T., Scheer, W. D., Roheim, P. S., McGill, H. C. Jr, Strong, J. P.
(1999). Lipid and Apolipoprotein Predictors of Atherosclerosis in Youth : Apolipoprotein Concentrations Do Not Materially Improve Prediction of Arterial Lesions in PDAY Subjects. Arterioscler. Thromb. Vasc. Bio.
19: 753-761
[Abstract][Full Text]
Ishikawa, Y., Akasaka, Y., Ishii, T., Komiyama, K., Masuda, S., Asuwa, N., Choi-Miura, N.-H., Tomita, M.
(1998). Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta. Arterioscler. Thromb. Vasc. Bio.
18: 665-672
[Abstract][Full Text]
Eberhart, G. P., Mendez, A. J., Freeman, M. W.
(1998). Decreased Cholesterol Efflux from Fibroblasts of a Patient without Tangier Disease, but with Markedly Reduced High Density Lipoprotein Cholesterol Levels. J. Clin. Endocrinol. Metab.
83: 836-846
[Abstract][Full Text]
Bachorik, P. S., Lovejoy, K. L., Carroll, M. D., Johnson, C. L.
(1997). Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III). Clin. Chem.
43: 2364-2378
[Abstract][Full Text]
Catalano, M., Perilli, E., Carzaniga, G., Scandale, G., Carotta, M.
(1997). Arterial Damage, Triglycerides, Apolipoprotein, and Lp-(a) Values in PVD Patients. CLIN APPL THROMB HEMOST
3: 104-109
[Abstract]
Blangero, J., Williams-Blangero, S., Mahaney, M. C., Comuzzie, A. G., Hixson, J. E., Samollow, P. B., Sharp, R. M., Stern, M. P., MacCluer, J. W.
(1996). Effects of a Major Gene for Apolipoprotein A-I Concentration Are Thyroid Hormone Dependent in Mexican Americans. Arterioscler. Thromb. Vasc. Bio.
16: 1177-1183
[Abstract][Full Text]
Jin, F.-Y., Kamanna, V. S., Chuang, M.-Y., Morgan, K., Kashyap, M. L.
(1996). Gemfibrozil Stimulates Apolipoprotein A-I Synthesis and Secretion by Stabilization of mRNA Transcripts in Human Hepatoblastoma Cell Line (Hep G2). Arterioscler. Thromb. Vasc. Bio.
16: 1052-1062
[Abstract][Full Text]
Lamarche, B., Moorjani, S., Lupien, P. J., Cantin, B., Bernard, P.-M., Dagenais, G. R., Despres, J.-P.
(1996). Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Quebec Cardiovascular Study. Circulation
94: 273-278
[Abstract][Full Text]
Abram, H. S., Knepper, L. E., Warty, V. S., Painter, M. J.
(1996). Natural History, Prognosis, and Lipid Abnormalities of Idiopathic Ischemic Childhood Stroke. J Child Neurol
11: 276-282
[Abstract]
Hachinski, V., Graffagnino, C., Beaudry, M., Bernier, G., Buck, C., Donner, A., Spence, J. D., Doig, G., Wolfe, B. M. J.
(1996). Lipids and Stroke: A Paradox Resolved. Arch Neurol
53: 303-308
[Abstract]
Takata, K., Saku, K., Ohta, T., Takata, M., Bai, H., Jimi, S., Liu, R., Sato, H., Kajiyama, G., Arakawa, K.
(1995). A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease. Arterioscler. Thromb. Vasc. Bio.
15: 1866-1874
[Abstract][Full Text]
Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., Sakai, M., Hakamata, H., Sakamoto, Y.-I., Naito, M., Ruan, Y., Takahashi, K., Ohta, T., Horiuchi, S.
(1995). Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits. Arterioscler. Thromb. Vasc. Bio.
15: 1882-1888
[Abstract][Full Text]
Bolibar, I., Thompson, S. G., von Eckardstein, A., Sandkamp, M., Assmann, G.
(1995). Dose-Response Relationships of Serum Lipid Measurements With the Extent of Coronary Stenosis : Strong, Independent, and Comprehensive. Arterioscler. Thromb. Vasc. Bio.
15: 1035-1042
[Abstract][Full Text]
Murakami, T., Komiyama, Y., Masuda, M., Karakawa, M., Iwasaka, T., Takahashi, H.
(1995). Evaluation of Factor XIa–{alpha}1-Antitrypsin in Plasma, a Contact Phase–Activated Coagulation Factor–Inhibitor Complex, in Patients With Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio.
15: 1107-1113
[Abstract][Full Text]
Soyal, S. M., Seelos, C., Lin-Lee, Y.-C., Sanders, S., Gotto, A. M. Jr., Hachey, D. L., Patsch, W.
(1995). Thyroid Hormone Influences the Maturation of Apolipoprotein A-I Messenger RNA in Rat Liver. J. Biol. Chem.
270: 3996-4004
[Abstract][Full Text]
O'Brien, T., Nguyen, T. T., Hallaway, B. J., Hodge, D., Bailey, K., Holmes, D., Kottke, B. A.
(1995). The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio.
15: 228-231
[Abstract][Full Text]
Probstfield, J. L., Hunninghake, D. B.
(1994). Nicotinic Acid as a Lipoprotein-Altering Agent: Therapy Directed by the Primary Physician. Arch Intern Med
154: 1557-1559
[Abstract]
Rosenson, R. S.
(1993). Low Levels of High-Density Lipoprotein Cholesterol (Hypoalphalipoproteinemia) An Approach to Management. Arch Intern Med
153: 1528-1538
[Abstract]
Endo, H., Takagi, Y., Nozue, T., Kuwahata, K., Uemasu, F., Kobayashi, A.
(1992). Beneficial Effects of Dietary Intervention on Serum Lipid and Apolipoprotein Levels in Obese Children. Arch Pediatr Adolesc Med
146: 303-305
[Abstract]
Houston, M.C., Olafsson, L., Burger, M.C.
(1991). Effects of Nifedipine GITS and Atenolol Monotherapy on Serum Lipids, Blood Pressure, Heart Rate, and Weight in Mild to Moderate Hypertension. ANGIOLOGY
42: 681-690
[Abstract]
Steinberg, D., Pearson, T. A., Kuller, L. H.
(1991). Alcohol and Atherosclerosis. ANN INTERN MED
114: 967-976
[Abstract]
Perez, G. O., Mendez, A. J., Goldberg, R. B., Duncan, R., Palomo, A., DeMarchena, E., Hsia, S.L.
(1990). Correlates of Atherosclerosis in Coronary Arteries of Patients Undergoing Angiographic Evaluation. ANGIOLOGY
41: 525-532
[Abstract]
Peters, N. L.
(1989). Snipping the Thread of Life: Antimuscarinic Side Effects of Medications in the Elderly. Arch Intern Med
149: 2414-2420
[Abstract]
DETRANO, R., FROELICHER, V.
(1987). A Logical Approach to Screening for Coronary Artery Disease. ANN INTERN MED
106: 846-852
[Abstract]
Superko, H. R., Bachorik, P. S., Wood, P. D.
(1986). High-Density Lipoprotein Cholesterol Measurements: A Help or Hindrance in Practical Clinical Medicine?. JAMA
256: 2714-2717
[Abstract]
Hoeg, J. M., Gregg, R. E., Brewer, H. B. Jr
(1986). An Approach to the Management of Hyperlipoproteinemia. JAMA
255: 512-521
[Abstract]
Deeb, S., Failor, A., Brown, B.G., Brunzell, J.D., Albers, J.J., Motulsky, A.G.
(1986). Molecular Genetics of Apolipoproteins and Coronary Heart Disease. Cold Spring Harb Symp Quant Biol
51: 403-409
[Abstract]
Camargo, C. A. Jr, Williams, P. T., Vranizan, K. M., Albers, J. J., Wood, P. D.
(1985). The Effect of Moderate Alcohol Intake on Serum Apolipoproteins A-I and A-II: A Controlled Study. JAMA
253: 2854-2857
[Abstract]
